Effectiveness of methotrexate as a second-line treatment for cardiac sarcoidosis assessed via (18)F-FDG PET: a case report

BACKGROUND: Although methotrexate has been widely used as a second-line therapy for cardiac sarcoidosis (CS), it is not clear if it has a direct anti-inflammatory effect. CASE SUMMARY: A 65-year-old man presented to our hospital with symptomatic ventricular tachycardia (VT). After cardioversion, ele...

Descripción completa

Detalles Bibliográficos
Autores principales: Dotare, Taishi, Maeda, Daichi, Matsue, Yuya, Minamino, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195226/
https://www.ncbi.nlm.nih.gov/pubmed/35712221
http://dx.doi.org/10.1093/ehjcr/ytac226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195226/
https://www.ncbi.nlm.nih.gov/pubmed/35712221
http://dx.doi.org/10.1093/ehjcr/ytac226

Ejemplares similares